My Cart 0 items

2-day In-person Seminar

Validation of Computer Systems for Production and Quality and Software Embedded Medical Devices


September 21st & 22nd, 2017

Time: 9:00 AM to 6:00 PM

Baltimore, MD

Venue: WILL BE ANNOUNCED SOON


Director : David R. Dills

**Please note the registration will be closed 2 days (48 Hours) prior to the date of the seminar.

  Price: $1,295.00
(Seminar Fee for One Delegate)

  Register for 5 attendees   Price: $3,885.00
      $6,475.00 You Save: $2,590.00 (40%)*
Register now and save $200. (Early Bird)
  • ?
    • Until August 10, Early Bird Price: $1,295.00 From August 11 to September 19, Regular Price: $1,495.00
Course "Validation of Computer Systems for Production and Quality and Software Embedded Medical Devices" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Why should you attend:

  • Understand Verification and Validation, differences and how they work together
  • Develop a "Working Definition" of V&V, Qualification, and related terms
  • Discuss recent regulatory expectations
  • Software Verification & Validation requirements of the FDA and ISO.
  • The latest FDA Software Guidance & Regulations, including Part 11 -impact on V&V strategies
  • Device and Manufacturing software requirements for V & V
  • How to determine & demonstrate an appropriate V & V strategy
  • How to determine & handle software for different Levels of Concern
  • What V&V is required for 3rd Party software-custom and Off-the-shelf
  • Impact of FDA, Mobile APPS, Cyber Security, and software standards such as IEC 62304
  • What to look for during software vendor audits.
  • V & V documentation and level of detail required for device submissions.
  • How to document a "risk-based" rationale, and use it in a resource-constrained environment
  • Determine key "milestones" and "tasks" in a project as well as discussing audience related projects for discussion points
  • Generate Master and Individual Validation Plans
  • Learn the key elements of a Product V&V protocol and expectations with the Summary Report
  • Develop Process and/or Production/Test Equipment V&V Files/Protocols
  • Sample sizes and their justification
  • Learn the key elements of Software V&V expected by the FDA and how to document appropriately and adequately
  • QMS Electronic Records and Electronic Signatures per 21 CFR 11
  • Regulatory Requirements for Software Validation and Benefits
  • Quality System Regulation vs Pre-Market Submissions
  • Software requirements in specifications
  • Verification and Validation process
  • IQ/OQ/PQ in software V&V and next steps for compliance
  • Software development as part of system Design
  • Software life cycle verification
  • Software validation after a change
  • Validation of Off-the-Shelf Software and Automated Equipment
  • What is Process Validation
  • What are FDA and international requirements for Process Validation
  • Process Validation & Equipment Qualification
  • Examples of successful Process Validation activities
  • Where and how does software validation integrate into the Validation Plan
  • Recent examples of FDA Warning Letter cites and other enforcement actions for non-compliant V&V findings...what went wrong
  • Seminar attendees are encouraged to bring examples of their work from the functional area on the various topics as applicable for group discussion
  • Review and discuss pain points, challenges and solutions
  • Guidance for Industry, Trends and FDA Inspection & Enforcement Statistics and Trends
  • Prepare for Regulatory Inspections, including FDA and Operate in a State of Readiness

Who will benefit:

This seminar will provide an overview and in-depth snapshot of the process for managing V&V activities affecting product, process, equipment and the QMS. Company employees responsible for new product development, regulatory submissions, initiating/overseeing company-wide V&V planning, using a risk-justified approach and responsible for some of the areas identified herein, certainly will benefit. Employees who will benefit include all levels of management and departmental representatives from key functional areas and those who desire a better understanding or a "refresh" overview of the V&V process with product, process, software and impact on the QMS from start to finish, with key emphasis on regulatory compliance and governance, including:

  • Regulatory Affairs Management
  • Regulatory Affairs Specialist
  • Auditors
  • Compliance
  • Quality Assurance Management
  • Engineering/Technical Services
  • Operations/Manufacturing
  • Consultants
  • Quality Assurance or Quality Control Professionals
  • IT/IS
  • R&D
  • Production Management
  • Manufacturing Engineers
  • Process Engineers
  • Software Engineers
  • Validation Engineers
  • Project Managers
  • Hardware and software vendors, sales and marketing

Day 1 Schedule


  • Introductions and Overview
  • Device Concepts, Software Requirements
  • Software Designs and Implementation Activities
  • Software Testing
  • Non-Device Validation
  • Software development life cycle (SDLC), including examples of commonly used SDLCs
  • Software V&V documentation
  • Electronic Records and Electronic Signatures (Part 11)
  • Software Embedded Medical Device Testing and Validation and Regulatory Expectations and Requirements
  • Software Standard Operating Procedures related to V&V
  • Software Quality Assurance Planning
  • Software Test Strategies & Methodologies
  • Requirements Validation
  • Verification and validation, including regulatory definitions, regulatory intent, and common tasks
  • Regulatory framework and the relationship of various sources of regulatory requirements
  • Key regulations, standards, and guidance documents
  • Integrating risk management processes
  • Design control and software validation guidance
  • Testing-level strategies (unit, integration, system, user)
  • Methods development and documentation requirements, plus test protocol content
  • Configuration management, change management, and maintenance strategies
  • Documentation requirements for premarket submissions
  • Processes, procedures, and outputs for typical phases (e.g., examples, roles, relationships)
  • Defects and issues management
  • Design and quality planning, including traceability and reviews
  • Lessons learned from case studies and warning letters
  • Design software validation plans that build confidence in the software and comply with regulatory requirements for device, commercial off-the-shelf, and Quality System software
  • Use risk management to focus validation activities to minimize risk
  • Streamline elements of the Quality System for cost-efficient software development and validation

Day 2 Schedule


  • Recap of Day 1
  • Regulatory Guidance and Regulations and Additional Resources
  • Select appropriate lifecycle models and synchronize validation activities for all types of software
  • Write unambiguous, testable requirements
  • Integrate best development engineering practices to support validation efforts
  • Organize test designs, test cases, and test procedures that effectively cover requirements being verified, and that provide opportunities for review and management of the process
  • Regulatory and Compliance Overview/FDA Snapshot on V&V for Manufacturers/Master Validation Planning
  • FDA's approach and Risk Management Tools with ISO 14971, ICH and other Guidance/Standards - Product, Process Equipment V&V Product/Device V&V
  • Software V&V and where and how does software validation integrate into the Validation Plan
  • Quality Management System/21 CFR Part 11 expectations and requirements
  • Avoid or Minimize Compliance Concerns and Issues: Q&A/FAQs and review of company documentation
  • Review of group activity and hands-on examples and activities show real-world implementation of useful governing principles, tools and templates and the most recent enforcement actions for trending, compliance and governance

Debrief/Adjourn

  • Recap of topics and key discussion points and take away message
  • FAQs and latest trends with industry and regulators
Want to register by P.O/Check?
We facilitate registration by P.O/Checks!
Complete your registration in just a few easy steps
Please just download, fill out the registration form and send it to us either by email to support@globalcompliancepanel.com or just fax us at 302 288 6884.
Once the form is received, an invoice will be generated and sent back to your fax number.
Following this just send us your purchase order by fax at 302 288 6884
Click here to download Registration form
In case you wish to register by using check
In case you wish to register by using check, please make a check to NetZealous LLC DBA GlobalCompliancePanel.com and mail it to the below address.
NetZealous LLC,
DBA GlobalCompliancePanel,
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA
Phone: 1800 447 9407

Want to register by Wire Transfer?
Please call any of our representatives on 1800 447 9407 to help you completed the transfer.
Group participations
Get fabulous discounts by participating in groups of two or more.
No Attendees Discount
1 2 Attendees 10% off
2 3 to 6 Attendees 20% off
3 7 to 10 Attendees 25% off
4 10+ Attendees 30% off

To avail the above group discounts, all the participants should register by making a single payment

Call our representative TODAY on 1800 447 9407 to have your seats confirmed!

David R. Dills

Regulatory Affairs & Compliance Consultant,

David R. Dills, Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape. Previously employed, with increasing responsibilities by device manufacturers and consultancies, including a globally recognized CRO, has worked directly with and for manufacturers engaged in compliance remediation activities involving consent decrees, CIA's, FDA warning letters, and customer generated compliance events, provides Strategic GxP Compliance and Regulatory Consulting, handles all aspects of global regulatory submissions and dossiers, including 510(k), PMA, Design Dossiers, Technical Files, CMC, NDA, and IDE submissions, currently serves as a U.S. Agent, works with stakeholders and Center Reviewers regarding submission meetings/negotiations, clinical affairs, and provides regulatory submissions and post-market project leadership/guidance covering different therapeutic and medical specialties based on classification. His background encompasses broad capabilities in regulatory and compliance oversight and governance, including CAPA, Design Controls, Validation, Software Quality with regulatory oversight, FDA Mock Inspections, remediating documentation management systems, Supplier Quality, Adverse Event Reporting, Product Complaints, GxP Training, interpretation and applicability of FDA and international regulations and standards, postmarketing surveillance, ISO 13485 and CE Mark, Medical Device/IVD/Active Implantable Directives. Mr. Dills leads and manages efforts involving multi-country product registrations and licensing in Asia Pacific, EMEA and The Americas from premarketing to postmarketing, and works with the Regulatory Authorities and strives to provide consistent, practical compliance solutions that work with reduction of regulatory compliance risk.

Location: Baltimore, MD Hotel: WILL BE ANNOUNCED SOON  

Copyright © 2016 GlobalCompliancePanel. All rights reserved. Netzealous